Sitemap
November 01, 2018 Articles
Filter by Available Specialty
- Cardiology Today’s top news from October
- ‘Reassuring’ evidence shows statin use does not impact flu vaccine effectiveness
- EFORT Open Reviews: A round-up of recently published articles
- Atrioventricular Nodal Reentry Tachycardia (AVNRT)
- Beyond tolvaptan, what lies ahead: New therapies in the treatment of polycystic kidney disease
- Biologic tapering successful, cost-effective in low-activity RA
- DJO announces the addition of new cementless primary, revision knee solutions
- Ebola vaccines demonstrate long-lasting immune response
- EFORT returns to Vienna for 21st Annual Congress and another fruitful learning event
- EPOS BAT Advanced Course in November 2018
- Eyevance acquires Flarex from Novartis
- FDA allows for expanded marketing of 23andMe to include medication metabolism
- FDA approves mobile app for Freestyle Libre
- FDA committees do not support buprenorphine/samidorphan for major depression
- FDA: Studies linking cellphone radiation to cancer in rats should not be applied to humans
- Genetic testing decoded: Discussing goals, limitations of direct-to-consumer tests
- In-hospital infections associated with higher rates of readmission for stroke patients
- Insurance-related disparities in dialysis linked with risk of vascular access infections
- Kids with measles vulnerable to developing infectious disease symptoms years later
- LATTE-2: Injectable ART regimen shows durable response over 160 weeks
- Learn how the 20th EFORT Congress can help you to manage TKA pain
- Longer breastfeeding duration lowers women’s risk for NAFLD
- Many PCPs do not discuss low-sodium diet for patients with kidney disease
- Mapping the future: Implementation strategies for kidney supportive care
- Medacta receives FDA clearance for kinematic alignment instrumentation for total knee replacement
- Modern aphrodisiacs address hypoactive sexual desire disorder
- New clinical research fellowship available through the EFORT Foundation
- Nintedanib combination therapy no better than monotherapy in some cases of idiopathic pulmonary fibrosis
- NSAIDs may be safe in chronic kidney disease
- Obinutuzumab-venetoclax combination extends PFS in treatment-naive chronic lymphocytic leukemia
- Optometrist, TAYE initiative increase awareness of vision health
- Oral steroids for nonarteritic anterior ischemic optic neuropathy did not significantly improve visual acuity
- Peripheral DCB safe, effective in real-world cohort with long lesions
- Phase 3 data support combination drug targeting opioid system for major depression
- Proposition 8 and how it may impact patient care
- Q&A: UEG research prize may help identify novel celiac disease risk factors
- Role of antithrombotic therapy evolving
- Roux-en-Y confers greater weight loss, adverse events vs. other bariatric procedures
- Seva Foundation sends delegates worldwide for World Sight Day
- Sodium bicarbonate treatment achieves improvements in endothelial function in stage 3b and 4 CKD
- Submission of session topics for 2020 EFORT Congress in Vienna
- The ACR Interviews: Martin J. Blaser, MD
- The impact of proposed evaluation and management code changes for nephrologists
- The unexpected perils of billing for PD services
- Top hematology/oncology stories: Palliative care could reduce suicide risk, FDA approves Khapzory for injection
- Understand the abstract selection process for the 20th EFORT Congress
- Understanding what the ‘customer’ wants in kidney care
- US surgeons now implanting Visian toric ICL
- Useful flaps for orthopaedic surgeons: 2019 edition of the famous EFORT Anatomical Course
- VIDEO: Expert highlights EUS research at ACG
- VIDEO: Long-term vision, refraction outcomes reviewed for IC-8
- VIDEO: Vision screenings important for underserved communities